alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
**Exhibit 31.2**
**CERTIFICATION**
I, D. Dwight Scott, certify that:
1. I have reviewed this Quarterly Report on Form 10-Q/A of El Paso Corporation;
2. Based on my knowledge, this Report does not contain any untrue statement of a materialfact or omit to state a material fact necessary to make the statements made, in light of thecircumstances under which such statements were made, not misleading with respect to theperiod covered by this Report;
3. Based on my knowledge, the financial statements, and other financial information includedin this Report, fairly present in all material respects the financial condition, results ofoperations and cash flows of the registrant as of, and for, the periods presented in thisReport;
4. The registrant’s other certifying officer(s) and I are responsible for establishing andmaintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e)and 15d-15(e)) for the registrant and have:
(a) Designed such disclosure controls and procedures, or caused such disclosurecontrols and procedures to be designed under our supervision, to ensure thatmaterial information relating to the registrant, including its consolidatedsubsidiaries, is made known to us by others within those entities, particularlyduring the period in which this Report is being prepared;
(b) Evaluated the effectiveness of the registrant’s disclosure controls andprocedures and presented in this Report our conclusions about the effectiveness ofthe disclosure controls and procedures, as of the end of the period covered by thisReport based on such evaluation; and
(c) Disclosed in this Report any change in the registrant’s internal control overfinancial reporting that occurred during the registrant’s most recent fiscal quarter(the registrant’s fourth fiscal quarter in the case of an annual report) that hasmaterially affected, or is reasonably likely to materially affect, the registrant’sinternal control over financial reporting; and
5. The registrant’s other certifying officer(s) and I have disclosed, based on our mostrecent evaluation of internal control over financial reporting, to the registrant’s auditorsand the audit committee of the registrant’s board of directors (or persons performing theequivalent functions):
(a) All significant deficiencies and material weaknesses in the design or operationof internal control over financial reporting which are reasonably likely toadversely affect the registrant’s ability to record, process, summarize and reportfinancial information; and
(b) Any fraud, whether or not material, that involves management or other employeeswho have a significant role in the registrant’s internal control over financialreporting.
Date: July 8, 2005         */s/ D. Dwight Scott*   D. Dwight Scott   Executive Vice President and Chief Financial Officer
EXHIBIT 32





      CERTIFICATION PURSUANT TO SECTION 06 OF THE SABANES-OXLEY ACT OF 2002
               (SUBSECTION (a) AND (b) OF SECTION 1350, CHAPTER 63
                        OF TITLE 18, UNITED STATES CODE)





     Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, subsections (a)
and (b) of Section 1350 , chapter 63 of Title 18, United States Code), each of
the undersigned officers of DuraVest, Inc., a Florida corporation (the
"Company"), does certify with respect to the Quarterly Report of the Company on
Form 10-QSB for the three months ended March 31, 2004 as filed with the
Securities and Exchange Commission (the "10-QSB Report") that: (1) the 10-QSB
Report fully complies with the requirements of Section 13(a) and 15(d) of the
Securities Exchange Act of 1934; and (2) the information contained in the 10-QSB
Report fairly presents in all material respects, the financial condition and
results of the Company.



                               DURAVEST, INC..

Dated:  May 10, 2004           By:  /s/ Patti Cooke
                                  --------------------------------------------
                                  Patti Cooke, President, Principal Executive,
                                  Financial  and Accounting Officer and Sole
                                  Director
The Logic Specification, Supporting Data and Test Cases, also known as the C-D-S-i Resources, 

work together to translate the federal Advisory Committee on Immunization Practices 

Recommendations to update C-D-S engines ensuring a patient receives the right immunization 

at the right time.

Supporting Data are structured representations of A-C-I-P recommendations. The data contain 

the series and dose information, per antigen, required to support evaluation and forecasting as 

defined in the Logic Specification.

In this quick guide, the Varicella Supporting Data will be used as an example to examine:

•

•

•

the Spreadsheet organization

the Series Tab, and

A Series Dose Example

Each Supporting Data file is organized by a series of tabs:

•

•

•

• 

•

The Series Overview tab,

The Change History tab,

The Immunity tab, 

The Contraindications tab, and

one or more Series tabs

Click to view each tab as well as a description of its contents. 

Take a few minutes to explore the Varicella Series tab by clicking each highlighted area of the 

sheet to view a description.

Now let’s focus on what we’ve learned using the following example.

Ashley realizes she missed son Max’s 2-month well-check visit and is concerned because he 

hasn’t received his first dose of Rotavirus. She brings him in at 15 weeks 2 days old. 

By looking at the Rotavirus Supporting Data, we see that the minimum age for dose 1 is 6 weeks 

and the maximum age is 15 weeks. 

What is the recommendation for Max? 
Since Max is 15 weeks and 2 days old, he is beyond the maximum age of 15 weeks and, 

therefore, should not receive the vaccine. 

Let’s work through another example. 

Susie brings in her 8-week-old son, Jimmy, for his well-check visit. 

Should Jimmy receive his first dose of DTap? 

Based on the Supporting Data, we can see he is:

- 

- 

older than 6 weeks

And since there is no Maximum Age, Jimmy meets all of the requirements for his first 

dose of DTap. 

This concludes the Reading Supporting Data overview. See the C-D-S-i Practice Exercises for 

additional information on reading the Supporting Data.
If there were a 

vaccine against 

cancer, wouldn’t 

you get it for 

your kids?

HPV vaccine is

cancer prevention. Talk to 

the doctor about vaccinating 

your 11–12 year old 

sons and daughters

against HPV.

www.cdc.gov/vaccines/teens

CS249596-P

Distributed by:
No. 11-261.

#### Charles Podaras, Petitioner v. City of Menlo Park, California, et al.

565 U.S. 978, 132 S. Ct. 510,

181 L. Ed. 2d 348,

2011 U.S. LEXIS 7813.

October 31, 2011.

Petition for writ of certiorari to the United States Court of Appeals for the Ninth Circuit denied.

Same case below, 427 Fed. Appx. 614.
|   | (1) The Report fully complies with the requirements of sections 13(a) or 15(d) of the Securities and Exchange Act of 1934; and |
|--------|--------------------------------------------------------------------------------------------------------------------------------|

|   | (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of 1st Source. |
|--------|---------------------------------------------------------------------------------------------------------------------------------------------------------|

| By | /s/ LARRY E. LENTYCH                               |   |
|----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------|

|   | Larry E. Lentych, Chief Financial Officer |
|--------|-------------------------------------------|

----
Flu Vaccine for 

Preteens and Teens

A yearly flu vaccine is the best way to protect your

child from flu and its potentially serious complications. 

Why should my child 

get a flu vaccine?

• Reduces the risk of flu illness 

• Reduces the risk of hospitalization from flu

• Can be life-saving in children

• May reduce illness severity among people who get vaccinated but still get sick with flu

• Reduces the chances that your child will have to miss school or other activities and you will have to miss 

work to care for them

• Helps reduce the spread of flu to family and friends, including babies younger than 6 months who are 

too young to get a flu vaccine, and older people who are more vulnerable to getting very sick from flu

• If your child has certain long-term health problems, they are at higher risk of developing serious flu 

complications.

When should my child 

be vaccinated? OCTOBER Preteens and teens should get a yearly flu vaccine by the end of October.

However, getting vaccinated later can still be beneficial. Vaccination should continue

to be given throughout the flu season, even into winter or later.

Where can my child get 

a flu vaccine?

Flu vaccines are available in many places, including doctor’s offices or clinics, and sometimes at local health 

departments, pharmacies, urgent care clinics, grocery stores, and schools. Visit vaccinefinder.org to find a 

place near you to get a flu vaccine and other recommended vaccines.

Are flu vaccines safe? Flu vaccines have a good safety record. Hundreds of millions of Americans have safely received flu vaccines 

for more than 50 years, and there has been extensive research supporting the safety of flu vaccines. 

Like any vaccine or medicine, flu vaccines can have side effects. When they occur, flu vaccine side effects are 

generally mild and go away on their own within a few days.

Fainting after any vaccine is more common among preteens and teens. To help avoid fainting and injuries 

related to fainting, preteens and teens should sit or lie down when they get a shot and for about 15 minutes 

after getting the shot.

How can I get help 

paying for these 

vaccines?

Most health insurance plans provide coverage for routine vaccinations. The Vaccines for Children (VFC) 

program also provides vaccines for children 18 years and younger who are uninsured, underinsured, 

Medicaid-eligible, American Indian, or Alaska Native. Learn more at www.cdc.gov/Features/VFCprogram.

Talk to your child’s doctor or nurse about the flu vaccine 

or visit www.cdc.gov/flu/prevent

Last updated JULY 2019
EXHIBIT 32

                            CERTIFICATION PURSUANT TO
                            18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                 SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


<PAGE>

EXHIBIT 32


                            CERTIFICATION PURSUANT TO
                            18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                 SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


In connection with the Quarterly Report of Dynadapt System, Inc. (the "Company")
on Form 10-QSB for the period ending July 31, 2006 as filed with the  Securities
and Exchange  Commission on the date hereof (the  "Report").  I, Wesley Whiting,
President of the company,  certify,  pursuant to 18 USC Section 1350, as adopted
pursuant to Section 906 of the  Sarbanes-Oxley  Act of 2002, that to the best of
my knowledge and belief.

        (1)     The Report fully complies with the requirements of Section 13(a)
                or 15(d) of the Securities Exchange Act of 1934; and

        (2)     The information  contained in the Report fairly presents, in all
                material  respects,  the  financial  condition  and  results  of
                operations of the Company.


                                         /s/ Wesley Whiting
                                         --------------------------------
                                         Wesley Whiting, President
<TABLE> <S> <C>

<PAGE>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
UNAUDITED BALANCE SHEET AND STATEMENT OF INCOME FOR THE PERIOD ENDED JUNE 30,
1999 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-START>                             MAR-31-1999
<PERIOD-END>                               JUN-30-1999
<CASH>                                       2,100,047
<SECURITIES>                                         0
<RECEIVABLES>                                    7,563<F1>
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                             2,129,062
<PP&E>                                               0
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                               2,129,062<F2>
<CURRENT-LIABILITIES>                           88,552
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             0
<OTHER-SE>                                   2,040,510<F3>
<TOTAL-LIABILITY-AND-EQUITY>                 2,129,062
<SALES>                                              0
<TOTAL-REVENUES>                                22,217<F4>
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                                56,646<F5>
<LOSS-PROVISION>                              (34,429)
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                               (34,429)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                           (34,429)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                  (34,429)
<EPS-BASIC>                                     .003
<EPS-DILUTED>                                     .003
<FN>
<F1>INCLUDES INTEREST ONLY.
<F2>INCLUDES $21,452 OF PREPAID INSURANCE.
<F3>INCLUDES RETAINED EARNINGS ONLY.
<F4>INCLUDES INTEREST INCOME ONLY.
<F5>INCLUDES LEGAL, ACCOUNTING, MANAGER, TRANSFER AGENT AND SETTLEMENT
ADMINISTRATION AND OTHER FEES.
</FN>


</TABLE>
No. 10-11193.

#### Lisa Jo Chamberlin, Petitioner v. Mississippi.

565 U.S. 976, 132 S. Ct. 497,

181 L. Ed. 2d 346,

2011 U.S. LEXIS 7887.

October 31, 2011.

Petition for writ of certiorari to the Supreme Court of Mississippi denied.

Same case below, 55 So. 3d 1046.
DLA FORM 1385, DEC 2006 PDF (DLA)

has successfully completed

QUALITY ASSURANCE CERTIFICATION

in the

Commodity

DIRECTOR/COMMANDER SUPERVISOR
No. 11-46.

#### Oren Adar, Individually and as Parent and Next Friend of J. C. A-S, a Minor, et al., Petitioners v. Darlene W. Smith, State Registrar and Director, Office of Vital Records and Statistics, Louisiana Department of Health and Hospitals.

565 U.S. 942, 132 S. Ct. 400,

181 L. Ed. 2d 257,

2011 U.S. LEXIS 7300.

October 11, 2011.

Petition for writ of certiorari to the United States Court of Appeals for the Fifth Circuit denied.

Same case below, 639 F.3d 146.
No. 10-11015.

#### Luis Martinez, Petitioner v. Eric H. Holder, Jr., Attorney General.

565 U.S. 862, 132 S. Ct. 202,

181 L. Ed. 2d 108,

2011 U.S. LEXIS 5989.

October 3, 2011.

Petition for writ of certiorari to the United States Court of Appeals for the Ninth Circuit denied.
November 5, 2021 DLA-SM-21-3203

DLA STRATEGIC MATERIALS ANNOUNCES 

BOA SALES FOR October 2021

Fort Belvoir, VA - The Defense Logistics Agency Strategic Materials today announced sales 

made under the following Basic Ordering Agreements (BOA) during October 2021. 

SOLICITATION:

DLA-Stockpile Materials-001 

UNIT QUANTITY 

SOLD

APPROX 

VALUE

COMPANY

Ferrochrome Amendment 001 LC ST

HC ST

1,145 $2.50M Profound Alloys

LLC, 

Veritas Alloys & 

Metals

Chromium Metal Amendment 001 ST 60

Tungsten Ores and Concentrates 

Amendment 001

Lbs W 189,846

Zinc Amendment 001 Lbs

NO

SALES

Tin Amendment 001 MT 20 $758K *

*If no company name appears, the single awardee name has been withheld

$662K

CCMA, LLC

Exotech, INC

$2.79M *
No. 11-5160.

#### Larry Buchanan, Petitioner v. Texas.

565 U.S. 892, 132 S. Ct. 276,

181 L. Ed. 2d 164,

2011 U.S. LEXIS 5643.

October 3, 2011.

Petition for writ of certiorari to the Court of Appeals of Texas, Fourth District, denied.
NO. 07-02-0241-CR

IN THE COURT OF APPEALS

FOR THE SEVENTH DISTRICT OF TEXAS

AT AMARILLO

PANEL C

JUNE 11, 2002

______________________________

JUSTIN SHEPHERD

Appellant

v.

THE STATE OF TEXAS, 

Appellee

_________________________________

FROM THE 47TH DISTRICT COURT OF POTTER COUNTY;

NO. 44,331-A; HON. DAVID GLEASON, PRESIDING

_______________________________

ABATEMENT AND REMAND

_______________________________

Before QUINN, REAVIS, and JOHNSON, JJ.

Appellant, Justin Shepherd filed a pro se notice of appeal on May 28, 2002 and a

motion to have an attorney appointed on June 10, 2002. Accordingly, we now abate this

appeal and remand the cause to the 47th District Court of Potter County (trial court) for

further proceedings. Upon remand, the trial court shall immediately cause notice of a

hearing to be given and, thereafter, conduct a hearing to determine the following: 

1. whether appellant desires to prosecute the appeal; 
2

2. whether appellant is indigent; 

3. whether counsel has been appointed to prosecute this appeal;

4. if counsel has not been appointed, whether appellant is entitled to appointed 

 counsel; and

5. whether the appellant is entitled to the preparation of a free appellate record. 

The trial court shall cause the hearing to be transcribed. Furthermore, the trial court shall

execute findings of fact and conclusions of law addressing the aforementioned issues and

disclosing the name, address, state bar number, and telephone and fax numbers of newly

appointed counsel, if any. The district court shall also cause to be developed 1) a

supplemental clerk’s record containing the findings of fact and conclusions of law and all

orders of the district court issued as a result of its hearing on this matter, and 2) a

reporter’s record transcribing the evidence and arguments presented at the

aforementioned hearing. Additionally, the district court shall cause the supplemental

clerk’s record to be filed with the clerk of this court on or before July 11, 2002. Should

further time be needed by the trial court to perform these tasks, then same must be

requested before June 11, 2002.

 It is so ordered. 

 Per Curiam 

 Do not publish.
DLM 4000.25, Volume 4

1

DIC FS1/FS2/GS1/GS2 FORMAT

SUMMARY BILLING RECORD

Field Legend Position(s) Entry and Instructions

DI Code 1-3 Enter 

FS1 or GS1 (net charge)

FS2 or GS2 (net credit).

Internal Service Use 4 Reserved for internal billed office use. 

Billing office will leave blank.

Record Count 5-7 Enter the number of detail billing records 

which support this summary billing record 

(note: may not exceed 494).

Appropriation/Fund 

Account (Credit)

8-18 Enter the appropriation/fund account of 

the billing office (to be reimbursed).

Billing Office (RI Code) 19-21 Enter the RI code of the billing office.

Internal Use 22-27 Reserved for the internal use of the billed 

office.

FMS Country Code 28-29 When non DoD Agencies are the billing 

office or when the billing is not for security 

assistance: leave blank.

Otherwise, enter the FMS Country Code.

Billed Office (DoDAAC) 30-35 Enter the DoDAAC of the billed office.

Year Within Decade and 

Month Billed

36-38 Enter the year (Y) within decade and the 

month (MM) in which the billing was 

prepared. E.g.; January 2000 will be 

entered as 001 (YMM).

Information Indicator 39 Enter an applicable code or leave blank.

Bill Number 40-44 Enter bill number.

Billing Office (DoDAAC) 45-50 Enter the DoDAAC of the billing office.

Blank 51 Leave blank.

Fund Code 52-53 Perpetuate from the supporting detail 

billing records.

Appropriation/Fund 

Account (Charge)

54-64 Enter the appropriation/fund account of 

the billed office (to be disbursed).
DLM 4000.25, Volume 4

2

Field Legend Position(s) Entry and Instructions

Amount 65-73 Enter the net charge or credit amount of 

the detail billing records supporting this 

summary billing record.

Year/Month Reported 74-76 Billing and Billed offices leave blank. 

The central accounts office of the billing 

office will enter the year within decade 

and month the reimbursement and 

disbursement is reported to Treasury on 

the Statement of Interfund Transactions. 

Blank 77-79 Leave blank.

Billed Office Identifier 80 Enter 

X to indicate SBR submitted by a billed 

office. Otherwise, leave blank.
Order entered October 2, 2019

In The 

## Court of Appeals Fifth District of Texas at Dallas

No. 05 - 19 - 00699 - CR No. 05 - 19 - 00 824 - CR JOSHUA LEWIS NEAL, Appellant

V. THE STATE OF TEXAS, Appellee On Appe al from the Criminal District Court No. 6

Dallas County, Texas Trial Court Cause No. F16 - 57003 - X & F18 - 52038 - X



### O RDER Before the Court is appellant’s September 20, 2019 motion for extension of time to file his brief. We GRANT the motion and ORDER appella nt’s brief due on or before November 1, 2019

. /s/ LANA MYERS JUSTICE
No. 11-6191.

#### Jorge Ibarra-Perez, Petitioner v. Millicent Warren, Warden.

565 U.S. 986, 132 S. Ct. 518,

181 L. Ed. 2d 364,

2011 U.S. LEXIS 7764.

October 31, 2011.

Petition for writ of certiorari to the United States Court of Appeals for the Sixth Circuit denied.
NOTICE OF NOT MEASUREMENT 

CANCELLATION SENSITIVE 

NOTICE OF 

CANCELLATION 

 NOT MEASUREMENT 

 SENSITIVE 

 

 MIL-HDBK-512A 

 NOTICE 1 

 15 October 2007 

DEPARTMENT OF DEFENSE 

HANDBOOK 

PARTS MANAGEMENT 

MIL-HDBK-512A, dated 31 October 2001, is hereby cancelled and superseded by 

MIL-STD-3018, Parts Management, dated 15 October 2007. 

Custodians: Preparing Activity: 

 Army-AV DLA-CC 

 Navy-AS (Project SDMP-2008-001) 

 Air Force-10 

 DLA-CC 

NOTE: The activities listed above were interested in this document as of the date of this 

document. Since organizations and responsibilities can change, you should verify the currency 

of the information above using the ASSIST Online database at http://assist.daps.dla.mil. 

AMSC N/A AREA SDMP 

Source: https://assist.dla.mil -- Downloaded: 2017-03-27T17:00Z

Check the source to verify that this is the current version before use.
No. 10-1546.

#### Derek Carder, Mark Bolleter, Drew Daugherty, and Andrew Kissinger, on Behalf of Themselves and All Others Similarly Situated, Petitioners v. Continental Airlines, Inc.

565 U.S. 930, 132 S. Ct. 369,

181 L. Ed. 2d 235,

2011 U.S. LEXIS 7013.

October 3, 2011.

Motion of John Marshall Law School Veterans Legal Support Center & Clinic, et al. for leave to file a brief as amici curiae granted. Petition for writ of certiorari to the United States Court of Appeals for the Fifth Circuit denied.

Same case below, 636 F.3d 172.